Find Reports

Select Report Type

Reimbursement Review

Displaying 851 - 875 of 1426

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Lurasidone	Latuda	Lurasidone	cdr_tracking_Latuda.pdf cdr_complete_Latuda_Jan-25-13_e.pdf	Schizophrenia	Do not list	Complete	Jul 3, 2012	Jan 23, 2013	SR0284-000
Jakavi for myelofibrosis	Jakavi	Ruxolitinib	pcodr-provfund_jakavi_myelo.pdf pcodr-jakavimyelofibro-fn-rec.pdf pcodr-jakavi-myelofibro-fn-cgr.pdf pcodr-jakavi-myelofibro-fn-egr.pdf pcodr-jakavi-myelofibro-in-rec.pdf pcodr-jakavi-pag-fdk-in-rec.pdf pcodr-jakavi-in-fdk-novartis.pdf pcodr-jakavi-pt-fdk-in-rec-cml.pdf pcodr-jakavi-coi-cml.pdf pcodr-jakavi-pt-fdkinrec-cpmnn.pdf pcodr-jakavi-coi-cpmnn.pdf	Myelofibrosis	Reimburse with clinical criteria and/or conditions	Complete	Jun 25, 2012	Jan 14, 2013	PC0012-000
Colesevelam hydrochloride	Lodalis	Colesevelam hydrochloride	cdr_tracking_lodalis.pdf cdr_complete_Lodalis_Decembe_21_12.pdf	Hypercholesterolemia	Do not list at the submitted price	Complete	Apr 27, 2012	Dec 19, 2012	SR0274-000
Mometasone/formoterol	Zenhale	Mometasone/formoterol	cdrr_tracking_Zenhale-RfA.pdf cdr_complete_Zenhale RfA_December_21_12.pdf	Asthma	List with clinical criteria and/or conditions	Complete	Jun 6, 2012	Dec 19, 2012	SF0281-000
Fidaxomicin	Dificid	Fidaxomicin	cdr_tracking_Dificid.pdf cdr_complete_Dificid_December_21_12.pdf	Clostridium difficile infection	Do not list at the submitted price	Complete	Jul 10, 2012	Dec 19, 2012	SR0285-000
Votrient for Soft Tissue Sarco...	Votrient	Pazopanib Hydrochloride	pcodr-provfund_votrient-sts.pdf pcodr-votrientsts-fn-rec.pdf pcodr-votrientsts-fn-cgr.pdf pcodr-votrientsts-fn-egr.pdf pcodr-votrientsts-in-rec.pdf pcodr-votrientsts-pcodr9.pdf pcodr-votrientsts-pcodr10.pdf pcodr-votrientsts-pcodr11.pdf	Soft Tissue Sarcoma	Do not reimburse	Complete	Jun 4, 2012	Nov 29, 2012	PC0009-000
Treanda for Chronic Lymphocyti...	Treanda	Bendamustine hydrochloride	pcodr_provfund_treandacllrel.pdf pcodr-treandacll-fn-rec.pdf pcodr-treandacll-fn-cgr.pdf pcodr-treandacll-fn-egr.pdf pcodr-treandacll-in-rec.pdf pcodr-treandacll-fn-pcodr1.pdf pcodr-treandacll-fn-pcodr2.pdf pcodr-treandacll-fn-pcodr3.pdf pcodr-treandacll-fn-pcodr4.pdf pcodr-treandacll-fn-pcodr12.pdf	Chronic Lymphocytic Leukemia (relapsed/refractory)	Do not reimburse	Complete	Apr 24, 2012	Nov 29, 2012	PC0011-000
Treanda for indolent Non-Hodgk...	Treanda	Bendamustine hydrochloride	pcodr_provfund_treandanhl.pdf pcodr-treandanhl-fn-rec.pdf pcodr-treandanhl-fn-cgr.pdf pcodr-treandanhl-fn-egr.pdf pcodr-treandanhl-in-rec.pdf pcodr-treandanhl-pcodr5.pdf pcodr-treandanhl-pcodr6.pdf pcodr-treandanhl-pcodr7.pdf pcodr-treandanhl-pcodr8.pdf pcodr-treandanhl-pcodr13.pdf	Non-Hodgkin Lymphoma and Mantle Cell Lymphoma	Reimburse	Complete	Apr 24, 2012	Nov 29, 2012	PC0010-000
Fampridine	Fampyra	Fampridine	cdr_tracking_Fampyra.pdf cdr_complete_Fampyra_Nov-30-12.pdf	Multiple sclerosis, improve walking disability	Do not list	Complete	Apr 16, 2012	Nov 28, 2012	SR0275-000
Ranibizumab injection	Lucentis	Ranibizumab injection	cdr_tracking_Lucentis-RVO-2.pdf cdr_complete_Lucentis RVO_Oct-22-12_e.pdf	Macular edema, secondary to retinal vein occlusion	List with clinical criteria and/or conditions	Complete	Apr 25, 2012	Oct 18, 2012	SR0276-000
Fesoterodine fumarate	Toviaz	Fesoterodine fumarate	cdr_tracking_Toviaz.pdf cdr_complete_Toviaz_Oct-22-12_e.pdf	Overactive bladder	List in a similar manner	Complete	Apr 27, 2012	Oct 18, 2012	SR0277-000
Xalkori for Advanced Non-Small...	Xalkori	Crizotinib	pcodr-xalkorinsclc-fn-rec.pdf pcodr-xalkorinsclc-fn-cgr.pdf pcodr-xalkorinsclc-fn-egr.pdf pcodr-xalkori-in-rec.pdf pcodr-xalkori-pag-fdk-in-rec.pdf pcodr-xalkori-in-fdk-pfizer.pdf pcodr_xalkorinsclc_lcc_in_fdk.pdf pcodr-xalkori-coi-lcc.pdf	Advanced Non-Small Cell Lung Cancer	Do not reimburse	Complete	Mar 26, 2012	Oct 4, 2012	PC0008-000
Plerixafor	Mozobil	Plerixafor	cdr_tracking_Mozobil.pdf cdr_complete_Mozobil_Sept-28-12_e.pdf	Hematopoietic stem cell mobilizer in non-Hodgkin's lymphoma and multiple myeloma	Do not list	Complete	Jan 24, 2012	Sep 26, 2012	SR0265-000
Afinitor for pancreatic neuroe...	Afinitor	Everolimus	pcodr-provfund_afinitor-pnet.pdf pcodr-afinitor-fn-rec.pdf pcodr-afinitor-pnets-fn-cgr.pdf pcodr-afinitor-pnets-fn-egr.pdf pcodr-afinitor-pnets-in-rec.pdf pcodr-afinitor-pag-fdk-in-rec.pdf pcodr-afinitor-in-fdk-novartis.pdf pcodr-afinitor-coi-cnets.pdf	Pancreatic Neuroendocrine Tumour	Reimburse with clinical criteria and/or conditions	Complete	Feb 27, 2012	Aug 30, 2012	PC0007-000
Indacaterol	Onbrez	Indacaterol	cdr_tracking_Onbrez.pdf cdr_complete_Onbrez_Aug-20-12_e.pdf	Chronic obstructive pulmonary disease	List in a similar manner	Complete	Feb 29, 2012	Aug 16, 2012	SR0273-000
Rivaroxaban	Xarelto	Rivaroxaban	cdr_tracking_Xarelto_DVT.pdf cdr_complete_Xarelto DVT_Aug-20-12_e.pdf	Deep-vein thrombosis without symptomatic pulmonary embolism	List with clinical criteria and/or conditions	Complete	Feb 27, 2012	Aug 16, 2012	SR0271-000
Rituximab	Rituxan	Rituximab	cdr_tracking_Rituxan-2.pdf cdr_complete_Rituxan-Aug_16-12_e.pdf	Granulomatosis with polyangiitis and microscopic polyangiitis	List with clinical criteria and/or conditions	Complete	Feb 24, 2012	Aug 16, 2012	SR0270-000
Halaven for Metastatic Breast ...	Halaven	Eribulin Mesylate	pcodr-provfund_halaven-mbc.pdf pcodr-halavenmb-fn-rec.pdf pcodr-halavenmb-fn-cgr.pdf pcodr-halavenmb-fn-egr.pdf pcodr-halaven-metbreast-in-rec.pdf pcodr-halaven-pag-fdk-in-rec.pdf pcodr-halaven-in-fdk-eisai.pdf pcodr-halavenmb-coi-cbcn.pdf pcodr-halavenmb-coi-ccsn.pdf	Metastatic Breast Cancer	Reimburse with clinical criteria and/or conditions	Complete	Feb 9, 2012	Aug 2, 2012	PC0005-000
Exenatide	Byetta	Exenatide	cdr_tracking_Byetta.pdf cdr_complete_Byetta_July-23-12.pdf	Diabetes mellitus, type 2	Do not list	Complete	Aug 23, 2011	Jul 19, 2012	SR0246-000
Prucalopride	Resotran	Prucalopride	cdr_tracking_Resotran.pdf cdr_complete_Resotran_July-23-12.pdf	Constipation, chronic	Do not list	Complete	Jan 30, 2012	Jul 19, 2012	SR0266-000
OnabotulinumtoxinA	Botox	OnabotulinumtoxinA	cdr_tracking_Botox.pdf cdr_complete_Botox_July-23-12.pdf	Neurogenic detrusor overactivity	List with clinical criteria and/or conditions	Complete	Jan 31, 2012	Jul 19, 2012	SR0268-000
Tocilizumab	Actemra	Tocilizumab	cdr_tracking_Actemra-2.pdf cdr_complete_Actemra-sJIA_July-23-12_e.pdf	Arthritis, juvenile idiopathic	List with clinical criteria and/or conditions	Complete	Jan 30, 2012	Jul 19, 2012	SR0267-000
Asenapine	Saphris	Asenapine	cdr_tracking_Saphris.pdf cdr_complete_Saphris-000-June 18_2012.pdf	Schizophrenia	Do not list	Complete	Dec 12, 2011	Jun 14, 2012	SR0262-000
Prasugrel	Effient	Prasugrel	cdr_tracking_Effient_Resub-1.pdf cdr_complete_Effient-Resubmission_June-18-12.pdf	Acute coronary syndrome	Do not list	Complete	Dec 12, 2011	Jun 14, 2012	SR0263-000
Apixaban	Eliquis	Apixaban	cdr_tracking_Eliquis.pdf cdr_complete_Eliquis_June-18-12_e.pdf	Venous thromboembolic events, prevention	List with clinical criteria and/or conditions	Complete	Dec 20, 2011	Jun 14, 2012	SR0264-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 601 - 602 of 602

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 851 - 875 of 2138

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
pemigatinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submission Stakeholder feedback on Draft Recommendation	Jun 9, 2022	Reimbursement Review		Complete	PC0252-000
aducanumab		Jun 9, 2022	Reimbursement Review		Withdrawn	SR0705-000
Systemic Thrombolysis by Alteplase for Acute Ischemic Stroke	Systemic Thrombolysis by Alteplase for Acute Ischemic Stroke	Jun 8, 2022	Health Technology Review	Rapid Review with Expert Input	Completed	RD0066-000
Monitoring Patients With Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy	Monitoring Patients With Psychotic Disorders for Clozapine-Induced Myocarditis …	Jun 6, 2022	Health Technology Review	Rapid Review		RC1429-000
Guidelines for Pediatric Immune Thrombocytopenia	Guidelines for Pediatric Immune Thrombocytopenia	Jun 3, 2022	Health Technology Review	Rapid Review		RC1426-000
CADTH Pharmaceutical Reviews Update — Issue 29		Jun 2, 2022	Reimbursement Review	Pharmaceutical Review Update
CADTH and the Canadian Institute for Health Information (CIHI) Real-World Evidence Feasibility Collaboration	CIHI (PPD001) - GLP1 for feedback.pdf	Jun 1, 2022	Health Technology Review	Technology Review	Completed	CP0027 - HC0019
Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Refractory or High-Risk Patients	Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Refracto…	May 31, 2022	Health Technology Review	Rapid Review	Completed	RC1430-000
bimekizumab	Recommendation and Reasons: Updated Recommendation and Reasons: Original Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	May 31, 2022	Reimbursement Review		Complete	SR0698-000
Stepped Care Models for Chronic Pain	Stepped Care Models for Chronic Pain	May 30, 2022	Health Technology Review	Technology Review	Completed	HC0034-000
Reconsolidation and Consolidation Therapies for the Treatment and Prevention of Post-Traumatic Stress Disorder	Reconsolidation and Consolidation Therapies for the Treatment and Prevention of…	May 26, 2022	Health Technology Review	Rapid Review	Completed	RC1424-000
Multiple myeloma	Multiple myeloma - Final Report	May 25, 2022	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0011-000
An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devices	An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devi…	May 24, 2022	Horizon Scan	Emerging Health Technologies	Completed	EH0102-000
Robotic-Assisted Spinal Surgery	Robotic-Assisted Spinal Surgery	May 24, 2022	Health Technology Review	Rapid Review		RC1427-000
Melatonin for the Treatment of Insomnia: A 2022 Update	Melatonin for the Treatment of Insomnia: A 2022 Update	May 24, 2022	Health Technology Review	Rapid Review	Completed	RC1422-000
Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer	Final Report	May 24, 2022	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0009-000
Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Detachment Surgery	Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following…	May 20, 2022	Health Technology Review	Rapid Review		RC1428-000
Pre-Surgical Screening Tools and Risk Factors for Chronic Post-Surgical Pain	Pre-Surgical Screening Tools and Risk Factors for Chronic Post-Surgical Pain	May 17, 2022	Health Technology Review	Technology Review	Completed	HC0023-000
dinutuximab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Clinician Input Stakeholder feedback on Draft Recommendation	May 17, 2022	Reimbursement Review		Complete	PC0222-000
Melatonin for the Treatment or Prevention of Delirium	Melatonin for the Treatment or Prevention of Delirium	May 17, 2022	Health Technology Review	Rapid Review	Completed	RC1421-000
An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer Disease	An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer D…	May 16, 2022	Horizon Scan	Emerging Health Technologies	Completed	EH0103-000
Clinical Effectiveness of Second Generation Injectable Antipsychotics	Clinical Effectiveness of Second Generation Injectable Antipsychotics	May 12, 2022	Health Technology Review	Rapid Review	Completed	RC1418-000
somatrogon	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder Feedback on Draft Recommendation	May 11, 2022	Reimbursement Review		Complete	SR0683-000
Cost-Effectiveness of Treatment for Pediatric Immune Thrombocytopenia	Cost-Effectiveness of Treatment for Pediatric Immune Thrombocytopenia	May 5, 2022	Health Technology Review	Rapid Review	Completed	RC1425-000
fedratinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Stakeholder feedback on Draft Recommendation Clinician Input	May 5, 2022	Reimbursement Review		Complete	PC0205-000

Provisional Funding Algorithm

Displaying 76 - 81 of 81